Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes

被引:82
作者
Harenberg, J [1 ]
机构
[1] Univ Hosp, Dept Internal Med & Geriatr, Mannheim, Germany
关键词
D O I
10.1111/j.1538-7933.2004.00647.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:547 / 550
页数:4
相关论文
共 27 条
[1]  
ALHENCGELAS M, 1994, THROMB HAEMOSTASIS, V71, P698
[2]   LOW-MOLECULAR-WEIGHT HEPARIN(S) [J].
BARROWCLIFFE, TW .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) :1-7
[3]   Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes [J].
Becker, RC ;
Spencer, FA ;
Gibson, M ;
Rush, JE ;
Sanderink, G ;
Murphy, SA ;
Ball, SP ;
Antman, EM .
AMERICAN HEART JOURNAL, 2002, 143 (05) :753-759
[4]  
Blombäck M, 1998, BLOOD COAGUL FIBRIN, V9, P1
[5]  
BRAN G, 1990, THROMB HAEMOSTASIS, V64, P506
[6]   Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy [J].
Bremme, K ;
van Rooijen, M ;
Yu, A ;
Blombäck, M .
BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (02) :149-155
[7]   DELAYED ELIMINATION OF ENOXAPARINE IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY [J].
CADROY, Y ;
POURRAT, J ;
BALADRE, MF ;
SAIVIN, S ;
HOUIN, G ;
MONTASTRUC, JL ;
VERNIER, I ;
BONEU, B .
THROMBOSIS RESEARCH, 1991, 63 (03) :385-390
[8]   Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin [J].
Chow, SL ;
Zammit, K ;
West, K ;
Dannenhoffer, M ;
Lopez-Candales, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06) :586-590
[9]  
Collignon F, 1995, THROMB HAEMOSTASIS, V15, P119
[10]   DOSE ADJUSTED HEPARIN TREATMENT OF DEEP VENOUS THROMBOSIS - A COMPARISON OF UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN [J].
HANDELAND, GF ;
ABILDGAARD, U ;
HOLM, HA ;
ARNESEN, KE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) :107-112